STAT3 and osteosarcoma: Liu et al. indicated that miR-221-3p, derived from M2-type TAMs, enhanced osteosarcoma cell proliferation and invasion via the JAK2/STAT3 pathway, targeting SOCS3, thereby exacerbating tumor malignancy (Liu et al., 2021).